bromodeoxyuridine has been researched along with Infectious Myelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Estevez, DA | 1 |
| McTigue, DM; Popovich, PG; Schonberg, DL | 1 |
2 other study(ies) available for bromodeoxyuridine and Infectious Myelitis
| Article | Year |
|---|---|
[Cervicodorsal myelitis secondary to infection by varicella zoster virus in an immunocompetent patient].
Topics: Acyclovir; Antiviral Agents; Arm; Athetosis; Bromodeoxyuridine; Drug Therapy, Combination; Herpes Zoster; Herpesvirus 3, Human; Humans; Hyperalgesia; Immunocompetence; Male; Methylprednisolone; Middle Aged; Movement Disorders; Myelitis; Neck; Neuralgia, Postherpetic; Somatosensory Disorders; Thorax; Virus Activation | 2013 |
Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Line; Cell Proliferation; Cell Transplantation; Ciliary Neurotrophic Factor; Disease Models, Animal; Female; Gene Expression Regulation; Lipopolysaccharides; Macrophage Activation; Myelitis; Oligodendroglia; Rats; Rats, Sprague-Dawley; Stem Cells; Time Factors; Toll-Like Receptor 2; Toll-Like Receptor 4; Zymosan | 2007 |